Catheter-based repair for severe tricuspid valve leak
Part of Heart & circulation clinical trials.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- Your tricuspid valve leak is severe, massive, or torrential (the worst grades) and symptoms continue despite taking heart medications for at least 30 days.
- You have not had prior surgery or a procedure to repair or replace your tricuspid valve.
- You do not have a pacemaker or defibrillator lead that would block the new device, and your heart team confirms you are a good candidate for this catheter-based repair.
- You agree to come back for all follow-up visits after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
This study tests a clip device to fix a leaky tricuspid valve without open-heart surgery. It may help people who have symptoms like breathlessness or swelling and are not good candidates for surgery.
This trial tests a procedure that uses a small clip to fix a leaky tricuspid valve in the heart. The goal is to reduce symptoms like shortness of breath and fatigue, and help you feel better in your daily life.
This study tests a new device to fix a leaking tricuspid valve (the valve that helps blood flow from the heart to the lungs) without open-heart surgery. It is for people with severe leaking that causes symptoms like shortness of breath or tiredness, and who are not good candidates for surgery.
Hear when a new Tricuspid Regurgitation Functional trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.